Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
Harbeck N, Saupe S, Jäger E, Schmidt M, Kreienberg R, Müller L, Otremba BJ, Waldenmaier D, Dorn J, Warm M, Scholz M, Untch M, de Wit M, Barinoff J, Lück HJ, Harter P, Augustin D, Harnett P, Beckmann MW, Al-Batran SE; PELICAN Investigators. Harbeck N, et al. Among authors: waldenmaier d. Breast Cancer Res Treat. 2017 Jan;161(1):63-72. doi: 10.1007/s10549-016-4033-3. Epub 2016 Oct 31. Breast Cancer Res Treat. 2017. PMID: 27798749 Free PMC article. Clinical Trial.
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial.
Honecker F, Harbeck N, Schnabel C, Wedding U, Waldenmaier D, Saupe S, Jäger E, Schmidt M, Kreienberg R, Müller L, Otremba B, Dorn J, Warm M, Al-Batran SE, de Wit M; PELICAN investigators. Honecker F, et al. Among authors: waldenmaier d. J Geriatr Oncol. 2018 Mar;9(2):163-169. doi: 10.1016/j.jgo.2017.09.009. Epub 2017 Oct 18. J Geriatr Oncol. 2018. PMID: 29055624 Clinical Trial.
Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting.
Freckmann G, Eichenlaub M, Waldenmaier D, Pleus S, Wehrstedt S, Haug C, Witthauer L, Jendle J, Hinzmann R, Thomas A, Eriksson Boija E, Makris K, Diem P, Tran N, Klonoff DC, Nichols JH, Slingerland RJ. Freckmann G, et al. Among authors: waldenmaier d. J Diabetes Sci Technol. 2023 Nov;17(6):1506-1526. doi: 10.1177/19322968231190941. Epub 2023 Aug 20. J Diabetes Sci Technol. 2023. PMID: 37599389 Review.
Evaluation of the Tolerability of a Steel Needle and an Adhesive for a Patch Pump.
Jendrike N, Freckmann G, Krauß C, Mende J, Waldenmaier D, Heinemann L, Trippe ZA, Websky S. Jendrike N, et al. Among authors: waldenmaier d. J Diabetes Sci Technol. 2023 Jul;17(4):1123-1125. doi: 10.1177/19322968231176835. Epub 2023 May 25. J Diabetes Sci Technol. 2023. PMID: 37226799 Free PMC article. No abstract available.
Continuous Glucose Deviation Interval and Variability Analysis (CG-DIVA): A Novel Approach for the Statistical Accuracy Assessment of Continuous Glucose Monitoring Systems.
Eichenlaub M, Stephan P, Waldenmaier D, Pleus S, Rothenbühler M, Haug C, Hinzmann R, Thomas A, Jendle J, Diem P, Freckmann G. Eichenlaub M, et al. Among authors: waldenmaier d. J Diabetes Sci Technol. 2022 Nov 3:19322968221134639. doi: 10.1177/19322968221134639. Online ahead of print. J Diabetes Sci Technol. 2022. PMID: 36329636
40 results